Condition: Colorectal Carcinoma · Advanced Adenomas (AA) · Sponsor: ADVANCED MARKER DISCOVERY S.L.
This is a prospective, multicenter, case-control study. The aim is to develop an optimized algorithm by combining the levels of molecular markers in plasma together with risk factors for developing colorectal cancer and clinical data of patients diagnosed with CRC or AA and healthy individuals.
This description comes directly from the study's public registry record.
Marta Jimenez · +34637899149 · mjimenez@amadix.com
Always discuss trial participation with your own doctor first.
| Hospital Clinico Universitario Lozano Blesa | Zaragoza, Aragon, Spain | Recruiting |
| Hospital Universitario de Cruces | Bilbao, Basque Country, Spain | Recruiting |
| Policlinica Gipuzkoa Hospital | Donostia / San Sebastian, Basque Country, Spain | Completed |
| Hospital Universitario Marques de Valdecilla | Santander, Cantabria, Spain | Terminated |
| Hospital Universitario de Salamanca | Salamanca, Castille and León, Spain | Recruiting |
| Hospital Sant Rafael | Barcelona, Catalonia, Spain | Completed |
| Hospital Universitario Vall d' Hebron | Barcelona, Catalonia, Spain | Completed |
| MD Anderson Cancer Centre | Madrid, Madrid, Spain | Active Not Recruiting |
| Hospital Centro Médico de Asturias | Oviedo, Principality of Asturias, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06889883